Orthotaxy, a French company that develops software-enabled surgery technologies, was acquired by Johnson & Johnson through its French affiliate Apsis for undisclosed terms. J&J is aiming to expand the application of Orthotaxy's early-stage robotic-assisted surgery technology for total and partial knee replacement to include other orthopedic surgeries and hopes to develop a solution that is cost-effective, easy to use and saves time in various care settings.
About 89% of scientists from the American Association for the Advancement of Science say crops improved by modern biotechnology are safe for human consumption. Recent research showed that no differences have been found that implicate a higher risk to human health and safety from biotech foods versus their nonbiotech counterparts.
An addition of $1.5 billion to an existing share repurchasing plan of Baxter was approved by the company's board of directors, bringing the repurchase authority to $2.3 billion. Share repurchasing will be done through private transactions at amounts and times established by the company or in the open market.
Medtronic's diabetes division saw a 17% increase in sales during the fiscal third quarter ending Jan. 26 and accounted for about 8% of the company's revenue after the MiniMed 670G system's completion of a priority access program. The company, which saw a shortfall in the supply of sensors for its diabetes devices, eyes market expansion with more products built on the same sensing technology and believes it can now meet future demand.
The Fraunhofer Centre for Applied Photonics and Mologic are working together to create a rapid, point-of-care test that will combine microfluidics and nanophotonic waveguides for the diagnosis of bacterial urinary tract infections and related antibiotic susceptibility in primary care settings. The project, which will be supported with $1.3 million in funding from SBRI Healthcare, involves other partners, including the University of Strathclyde, Kelvin Nanotechnology, Wideblue and Barclay Medical Practice.
Scott Drake, a director at AtriCure, was tapped to serve as chairman of the board at the company beginning in May. Drake, former CEO of Spectranetics, will succeed Richard Johnston, who is retiring from the board.
The Dario blood glucose monitoring system is now on the Amazon marketplace, giving DarioHealth more purchasing and shipping options. The system synchronizes with Dario's diabetes management app and allows diabetes patients to track their glucose levels through the day by connecting to a mobile device through a headphone jack.
The FDA granted Siemens Healthineers clearance to market its GOKnee3D MRI software application, which is available for the company's MAGNETOM Aera 1.5T and MAGNETOM Skyra 3T MRI systems. The application, which Siemens aims to roll out for more of its MRI scanners in the future, allows for a 10-minute push-button diagnostic 3D knee exam and comes with machine learning- and artificial intelligence-based automated field-of-view adaptation.
The MS Society Tissue Bank is in its 20th year of brain and spinal cord tissue collection, which is used in multiple sclerosis research projects all over the world. More than 700 people have donated in the bank, but there is continued demand from MS researchers.
Massachusetts Eye and Ear Infirmary surgeon Emma Davies says cornea transplants are the best treatment for Fuchs dystrophy. "There's not a day that goes by that I don't think of, with gratitude, of that family or the patient who made that decision so that now I can see," transplant recipient Mary Lou Hackett said.